|
Sandmeyer Appointed to CIRM Board
|
|
|
|
Suzanne Sandmeyer, PhD, professor and Grace Beekhuis Bell chair of biological chemistry, professor of microbiology and molecular genetics and vice dean for research at the UCI School of Medicine, and professor of chemical engineering and materials science at The Henry Samueli School of Engineering, has been appointed to the governing board of the California Institute for Regenerative Medicine (CIRM), the state’s Stem Cell Agency. Sandmeyer was recommended for the position by UCI Chancellor Howard Gillman who called her “an outstanding researcher who has contributed significantly to the field of molecular genetics.” Honored to be chosen to join CIRM’s board Sandmeyer commented, “It is a privilege to be involved in this new era of stem cell research and clinical trials. We have only just begun to understand the potential of our discoveries and the impact we can have on human health by advancing stem cell therapies.” Jonathan Thomas, PhD, JD, chair of the CIRM Board, welcomed the appointment saying, “Dr. Sandmeyer will be a great addition to the board. She has a distinguished career, not just as a highly regarded scientist but also as a leader in helping the University of California, Irvine become the great research institution it is today.” CIRM was created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency to succeed in that mission. To meet this challenge, the CIRM team of highly trained and experienced professionals actively partners with both academia and industry in a hands-on, entrepreneurial environment to fast track the development of today’s most promising stem cell technologies. With $3 billion in funding and approximately 300 active stem cell programs in their portfolio, CIRM is the world’s largest institution dedicated to helping people by bringing the future of cellular medicine closer to reality.
|
|
|
Back to Top
|
|
|
|